Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew N Phillips

Showing results (41-50 of 287) with videos related to

Pageof 29
Sort By:
Plos One|August 21, 2012
Cost-effectiveness of tenofovir instead of zidovudine for use in first-line antiretroviral therapy in settings without virological monitoringViktor von Wyl, Valentina Cambiano, Michael R Jordan, et al.
AIDS (London, England)|December 4, 2004
Causes of death in HIV infection: the key determinant to define the clinical response to anti-HIV therapyAmanda Mocroft, Jose Gatell, Peter Reiss, et al.
Antiviral Therapy|February 22, 2007
HIV-1 subtypes and response to combination antiretroviral therapy in EuropeWendy P Bannister, Lidia Ruiz, Clive Loveday, et al.
Plos One|September 11, 2014
Potential future impact of a partially effective HIV vaccine in a southern African settingAndrew N Phillips, Valentina Cambiano, Fumiyo Nakagawa, et al.
Lancet (London, England)|November 22, 2002
Markers of HIV-1 disease progression in individuals with haemophilia coinfected with hepatitis C virus: a longitudinal studyCaroline A Sabin, Anja Griffioen, Thynn Thynn Yee, et al.
The Journal of Infectious Diseases|May 14, 2008
Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up, Jens D Lundgren, Abdel Babiker, et al.
HIV Medicine|August 29, 2023
Estimating the hospital costs of care for people living with HIV in England using routinely collected dataAlec Miners, Fiona C Lampe, Valentina Cambiano, et al.
Journal of Virus Eradication|November 23, 2019
Associations between baseline characteristics, CD4 cell count response and virological failure on first-line efavirenz + tenofovir + emtricitabine for HIVOliver T Stirrup, Caroline A Sabin, Andrew N Phillips, et al.
AIDS (London, England)|November 18, 2011
Projected life expectancy of people with HIV according to timing of diagnosisFumiyo Nakagawa, Rebecca K Lodwick, Colette J Smith, et al.
Journal of the International AIDS Society|August 31, 2017
Early virological response to HIV treatment: can we predict who is likely to experience subsequent treatment failure? Results from an observational cohort study, London, UKNataliya Brima, Fiona C Lampe, Andrew Copas, et al.
Pageof 29

Showing results (41-50 of 287) with videos related to

Sort By:
Pageof 29
Plos One|August 21, 2012
Cost-effectiveness of tenofovir instead of zidovudine for use in first-line antiretroviral therapy in settings without virological monitoringViktor von Wyl, Valentina Cambiano, Michael R Jordan, et al.
AIDS (London, England)|December 4, 2004
Causes of death in HIV infection: the key determinant to define the clinical response to anti-HIV therapyAmanda Mocroft, Jose Gatell, Peter Reiss, et al.
Antiviral Therapy|February 22, 2007
HIV-1 subtypes and response to combination antiretroviral therapy in EuropeWendy P Bannister, Lidia Ruiz, Clive Loveday, et al.
Plos One|September 11, 2014
Potential future impact of a partially effective HIV vaccine in a southern African settingAndrew N Phillips, Valentina Cambiano, Fumiyo Nakagawa, et al.
Lancet (London, England)|November 22, 2002
Markers of HIV-1 disease progression in individuals with haemophilia coinfected with hepatitis C virus: a longitudinal studyCaroline A Sabin, Anja Griffioen, Thynn Thynn Yee, et al.
The Journal of Infectious Diseases|May 14, 2008
Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up, Jens D Lundgren, Abdel Babiker, et al.
HIV Medicine|August 29, 2023
Estimating the hospital costs of care for people living with HIV in England using routinely collected dataAlec Miners, Fiona C Lampe, Valentina Cambiano, et al.
Journal of Virus Eradication|November 23, 2019
Associations between baseline characteristics, CD4 cell count response and virological failure on first-line efavirenz + tenofovir + emtricitabine for HIVOliver T Stirrup, Caroline A Sabin, Andrew N Phillips, et al.
AIDS (London, England)|November 18, 2011
Projected life expectancy of people with HIV according to timing of diagnosisFumiyo Nakagawa, Rebecca K Lodwick, Colette J Smith, et al.
Journal of the International AIDS Society|August 31, 2017
Early virological response to HIV treatment: can we predict who is likely to experience subsequent treatment failure? Results from an observational cohort study, London, UKNataliya Brima, Fiona C Lampe, Andrew Copas, et al.
Pageof 29